十月稻田(09676.HK)授出總計1394萬股獎勵股份
格隆匯7月16日丨十月稻田(09676.HK)公告,於2025年7月16日,董事會議決建議採納股份獎勵計劃。該股份獎勵計劃須經股東於臨時股東大會上審議及批準後生效。
於2025年7月16日,以股份獎勵計劃生效爲條件,公司建議向王兵先生、趙文君女士、舒明賀先生、趙淑蘭女士(各自爲公司執行董事及關連人士),及趙淑娟女士及趙文臣先生(各自爲公司僱員參與者及關連人士)授出總計1394萬股獎勵股份(可予調整)。根據有條件授予,受託人將最多動用供款金額1億港元(即相當於有條件授予項下承授人須全額支付的購買價),按聯交所現行市價購入獎勵股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.